182 results on '"Rueda IS"'
Search Results
2. Natural Language Processing for Automated Classification of Qualitative Data From Interviews of Patients With Cancer
3. Machine Learning Methods in Health Economics and Outcomes Research—The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force
4. A scoping review & taxonomy of epidemiological-macroeconomic models of COVID-19
5. EE306 Cost-Effectiveness Analysis of Treatments in Chronic Kidney Disease in Mexico
6. EE306 Cost-Effectiveness Analysis of Treatments in Chronic Kidney Disease in Mexico
7. POSA103 Estimation of the Economic and Social Burden of Pulmonary Arterial Hypertension in Spain
8. POSB237 Measures to Evaluate Quality of Care in Head and Neck Cancer: Interim Results of a Delphi Study
9. POSB237 Measures to Evaluate Quality of Care in Head and Neck Cancer: Interim Results of a Delphi Study
10. EE563 Cost-Effectiveness Analysis of Switching from a Trivalent to a Quadrivalent Inactivated Influenza Vaccine in Colombia
11. PCN226 Defining a Standard Set of Health Outcomes for Patients with Squamous Cell Carcinoma of the Head and Neck in Spain
12. PSU19 CHARACTERIZATION OF ADVERSE EVENTS IN THE SERVICE OF PLASTIC AND RECONSTRUCTIVE SURGERY IN HOSPITAL INSTITUTIONS OF BARRANQUILLA, 2016-2017
13. PSU19 CHARACTERIZATION OF ADVERSE EVENTS IN THE SERVICE OF PLASTIC AND RECONSTRUCTIVE SURGERY IN HOSPITAL INSTITUTIONS OF BARRANQUILLA, 2016-2017
14. PAM4 HEALTHCARE UTILIZATION AND HOSPITALIZATION COSTS AMONG FRAIL AND AT-NUTRITIONAL RISK OR MALNOURISHED OLDER ADULTS
15. PAM3 INDIVIDUALIZED NUTRITIONAL SUPPORT IN MEDICAL INPATIENTS RESULTS IN COST SAVINGS: ECONOMIC EVALUATION OF THE EFFORT TRIAL
16. PNS206 CAN WE IMPROVE THE ESTIMATION OF CENSORED COST DATA USING RANDOM FORESTS?
17. PRS12 ALIGNING COPD OUTCOMES WITH PATIENT-INFORMED VALUE ELEMENT DOMAINS FOR USE IN ECONOMIC EVALUATIONS
18. MT4 COST UTILITY ANALYSIS UPDATE OF DEEP BRAIN STIMULATION VS. BEST MEDICAL TREATMENT IN THE MANAGEMENT OF PARKINSON DISEASE WITH EARLY MOTOR COMPLICATIONS IN COLOMBIA
19. PAM3 INDIVIDUALIZED NUTRITIONAL SUPPORT IN MEDICAL INPATIENTS RESULTS IN COST SAVINGS: ECONOMIC EVALUATION OF THE EFFORT TRIAL
20. PAM4 HEALTHCARE UTILIZATION AND HOSPITALIZATION COSTS AMONG FRAIL AND AT-NUTRITIONAL RISK OR MALNOURISHED OLDER ADULTS
21. PNS206 CAN WE IMPROVE THE ESTIMATION OF CENSORED COST DATA USING RANDOM FORESTS?
22. PRS12 ALIGNING COPD OUTCOMES WITH PATIENT-INFORMED VALUE ELEMENT DOMAINS FOR USE IN ECONOMIC EVALUATIONS
23. MT4 COST UTILITY ANALYSIS UPDATE OF DEEP BRAIN STIMULATION VS. BEST MEDICAL TREATMENT IN THE MANAGEMENT OF PARKINSON DISEASE WITH EARLY MOTOR COMPLICATIONS IN COLOMBIA
24. CN4 - COMPARISON OF MACHINE LEARNING ALGORITHMS FOR THE PREDICTION OF MISSING CROSS-SECTIONAL COST DATA
25. Cost-Utility Analysis of Initial Treatment with Apremilast Versus Methotrexate in Systemic-Naïve Patients with Plaque Psoriasis
26. The Effect of Generic Statin Availability on Initial Statin Prescribing Trends Among Medicare Beneficiaries
27. CN4 - COMPARISON OF MACHINE LEARNING ALGORITHMS FOR THE PREDICTION OF MISSING CROSS-SECTIONAL COST DATA
28. Cost-Utility Analysis of Initial Treatment with Apremilast Versus Methotrexate in Systemic-Naïve Patients with Plaque Psoriasis
29. The Effect of Generic Statin Availability on Initial Statin Prescribing Trends Among Medicare Beneficiaries
30. Cost-Effectiveness of Lidocaine Medicated Patch Compared with Pregabalin and Gabapentin for the Treatment of Postherpetic Neuralgia an Diabetic Polyneuropathy in Colombia
31. Prospective Evaluation Of Patient-Centered Care In Short-Term Cancer Survivors, At One And Two Years Post Treatment, Through The Patient Assessment Of Chronic Illness Care Questionnaire
32. Costo-Utilidad de Un Esquema Inicial de Tratamiento Con Tofacitinib Comparado Con Terapia Biologica Anti-Tnf en Pacientes Adultos Con Artritis Reumatoide Que Han Presentado Respuesta Inadecuada a Metotrexato en Venezuela
33. Costs Of Ischemic Stroke With And Without Atrial Fibrillation In Colombia
34. Systematic Review of International Models of Care on Rare Diseases
35. Prospective Evaluation Of Patient-Centered Care In Short-Term Cancer Survivors, At One And Two Years Post Treatment, Through The Patient Assessment Of Chronic Illness Care Questionnaire
36. ASSESSING THE EFFECT OF FORMULARY RESTRICTIONS ON ANTIHYPERGLYCEMIC DRUGS
37. CURRENT STATUS OF SPONDYLOARTHROPATHIES IN COLOMBIA
38. Costo-Efectividad De La Vacuna Contra El Dengue 2014
39. Evaluation Of Patient-Centered Care In Short-Term Cancer Survivors, Through The Patient Assessment Of Chronic Illness Care Questionnaire
40. Costs Of Ischemic Stroke With And Without Atrial Fibrillation In Colombia
41. Costs and Consequences of Oral Anticoagulation in Atrial Fibrillation in Colombia
42. Budget Impact Analysis of Renal Post-Transplant Prophylaxis with Belatacept in Colombia
43. Cost-Utility of Apixaban Compared to Warfarin for Stroke Prevention in Patients with Atrial Fibrillation in Colombia
44. A Cost-Consequence Analysis of Different Protease Inhibitors Schemes for HIV Treatment from the Colombian Health Care System Perspective
45. CURRENT STATUS OF SPONDYLOARTHROPATHIES IN COLOMBIA
46. ASSESSING THE EFFECT OF FORMULARY RESTRICTIONS ON ANTIHYPERGLYCEMIC DRUGS
47. PMS32 ECONOMIC EVALUATION OF THE TREATMENT OF RHEUMATOID ARTHRITIS WITH ANTI-TNF BIOLOGICAL THERAPIES IN COLOMBIA
48. Evaluation Of Patient-Centered Care In Short-Term Cancer Survivors, Through The Patient Assessment Of Chronic Illness Care Questionnaire
49. Costo-Utilidad de Un Esquema Inicial de Tratamiento Con Tofacitinib Comparado Con Terapia Biologica Anti-Tnf en Pacientes Adultos Con Artritis Reumatoide Que Han Presentado Respuesta Inadecuada a Metotrexato en Venezuela
50. Evaluacion Economica Del Manejo Farmacologico Del Paciente Con Hiperplasia Prostatica Benigna En Colombia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.